ASSESSMENT OF PHARMACEUTICAL CARE SERVICES ON HEALTH RELATED QOL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS â€“ A PROSPECTIVE INTERVENTIONAL STUDY
Keywords:Patient counseling, KAP, Patient information leaflet and Quality of life
Background: In the last three decades role of pharmacist has changed dramatically. Patient counselling by pharmacist deals with providing information to the patients regarding the disease, Medications and lifestyle modifications. Diabetes mellitus (DM) is a severe medical and social problem that affects patient's general wellbeing. Despite of the advances in understanding the disease and its management, the morbidity and mortality rate are in rise.
Objective: To study the impact of pharmaceutical care services on quality of life in type 2 diabetes mellitus. To improve the knowledge, practice abd attitude, Quality of life of patients towards disease management.
Methods: This is a prospective intervention study. It was carried out to determine the quality of life, based on which patients were counselled regarding disease, medication, nutrition, exercise, insulin, foot care, eye care, personal hygiene, self monitoring of glucose and self care. Out of 80 patients, who are having diabetes mellitus and given patient counseling again collected after 1st and 2nd month. The paired t-test in Graph Pad InStat was used for statistical calculation.
Results: The overall KAP scores for diabetes patients between test of baseline and final follow up was statistically significant (P< 0.001). The test group has shown increased medication adherence than control which shows the importance of patient counseling.
Conclusion: The study concluded that pharmacist mediated patient counseling and the disease, medications and lifestyle modifications will improve the knowledge, attitude and practice, Quality of life and Glycemic control.
Marc A, Ronald E, Bruce H, P. Redekop Ken, Health related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes diabetes care. J Diabetes Care. 2002;(25):458-63.
O. WH. guidelines Management of Diabetes mellitus-Standards of care and clinical practice guidelines. J Diabetes Care.
Dekker JM, van der Kraan M, Nijpels G, de Vegt F, Kostense PJ, Stehouwer CDA, et al. [Estimate of the number of new patients with type 2 diabetes mellitus in the Netherlands:at least 65,000 per year in the age group of 50 years and above]. J Ned Tijdschr Geneeskd 2003;147(29):1419-23.
Mohan V, Sandeep S et al. Epidemiology of type of diabetes:indian scenario. Indian J of Medical Res 2007.
Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes:estimates for the year 2000 and projections for 2030. J Diabetes Care 2004;27(5):1047-53.
Aekplakorn et al. Thai Multicenter Research Group on Diabetes Mellitus. J Diabetes Care 1994;2003.
King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025:prevalence, numerical estimates, and projections. J Diabetes Care 1998;21(9):1414-31.
Marc A, Ronald P, Guy E, Bruce H. Redekop Ken, Health related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes. J Diabetes care 2002;25:458-63.
Jonsson B, Type, II. Revealing the cost of diabetes in Europe. J Diabetologia 2002;45:S5-12.
I. USP medication counseling behaviour guideline. USP DI update volumes I and the United States. J Pharmacopeia Convention Inc 17391748.1997:664-75.
Kannel WB, Mc Gee DL. Diabetes and cardiovascular disease. The Framingham study. J of the American Medical Association 1979;241(19):2035-8.